Works by Takeda, Masayuki


Results: 204
    1
    2

    Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.

    Published in:
    2016
    By:
    • Satomi Watanabe;
    • Hidetoshi Hayashi;
    • Kunio Okamoto;
    • Kimiko Fujiwara;
    • Yoshikazu Hasegawa;
    • Hiroyasu Kaneda;
    • Kaoru Tanaka;
    • Masayuki Takeda;
    • Kazuhiko Nakagawa;
    • Watanabe, Satomi;
    • Hayashi, Hidetoshi;
    • Okamoto, Kunio;
    • Fujiwara, Kimiko;
    • Hasegawa, Yoshikazu;
    • Kaneda, Hiroyasu;
    • Tanaka, Kaoru;
    • Takeda, Masayuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).

    Published in:
    Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
    By:
    • Sakai, Kazuko;
    • Takahama, Takayuki;
    • Shimokawa, Mototsugu;
    • Azuma, Koichi;
    • Takeda, Masayuki;
    • Kato, Terufumi;
    • Daga, Haruko;
    • Okamoto, Isamu;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Nishio, Kazuto
    Publication type:
    Article
    14
    15
    16
    17

    Exploring the size of reference population for expected accuracy of genomic prediction using simulated and real data in Japanese Black cattle.

    Published in:
    BMC Genomics, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12864-021-08121-z
    By:
    • Takeda, Masayuki;
    • Inoue, Keiichi;
    • Oyama, Hidemi;
    • Uchiyama, Katsuo;
    • Yoshinari, Kanako;
    • Sasago, Nanae;
    • Kojima, Takatoshi;
    • Kashima, Masashi;
    • Suzuki, Hiromi;
    • Kamata, Takehiro;
    • Kumagai, Masahiro;
    • Takasugi, Wataru;
    • Aonuma, Tatsuya;
    • Soma, Yuusuke;
    • Konno, Sachi;
    • Saito, Takaaki;
    • Ishida, Mana;
    • Muraki, Eiji;
    • Inoue, Yoshinobu;
    • Takayama, Megumi
    Publication type:
    Article
    18
    19
    20
    21
    22
    24
    25

    Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).

    Published in:
    International Journal of Urology, 2019, v. 26, n. 3, p. 342, doi. 10.1111/iju.13868
    By:
    • Yamaguchi, Osamu;
    • Kakizaki, Hidehiro;
    • Homma, Yukio;
    • Igawa, Yasuhiko;
    • Takeda, Masayuki;
    • Nishizawa, Osamu;
    • Gotoh, Momokazu;
    • Yoshida, Masaki;
    • Yokoyama, Osamu;
    • Seki, Narihito;
    • Okitsu, Akira;
    • Hamada, Takuya;
    • Kobayashi, Akiko;
    • Kuroishi, Kentaro
    Publication type:
    Article
    26
    27
    28
    29
    30

    Clinical guidelines for overactive bladder.

    Published in:
    International Journal of Urology, 2009, v. 16, n. 2, p. 126, doi. 10.1111/j.1442-2042.2008.02177.x
    By:
    • Yamaguchi, Osamu;
    • Nishizawa, Osamu;
    • Takeda, Masayuki;
    • Yokoyama, Osamu;
    • Homma, Yukio;
    • Kakizaki, Hidehiro;
    • Obara, Kenji;
    • Gotoh, Momokazu;
    • Igawa, Yasuhiko;
    • Seki, Naarihito;
    • Yoshida, Masaki
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Clinical benefits of adding olanzapine to 5-HT<sub>3</sub> receptor antagonist, NK<sub>1</sub> receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    2025
    By:
    • Murakami, Michiyasu;
    • Miyata, Yoshiharu;
    • Nakashima, Kazuhisa;
    • Abe, Masakazu;
    • Nishimura, Junichi;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakamura, Naoki;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    45

    Efficacy and safety of multi-day antiemetic treatment for patients undergoing multi-day chemotherapy: a systematic review of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology.

    Published in:
    2025
    By:
    • Nakashima, Kazuhisa;
    • Harashima, Saki;
    • Kaneko, Rena;
    • Tanaka, Ryuhei;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Literature Review
    46

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with moderately emetogenic chemotherapy: a systematic review and meta-analysis of Clinical Practice Guidelines for Antiemesis 2023 from Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1785, doi. 10.1007/s10147-024-02643-8
    By:
    • Nakashima, Kazuhisa;
    • Yokomizo, Ayako;
    • Murakami, Michiyasu;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    47

    Efficacy and safety of dexamethasone sparing for the prevention of nausea and vomiting associated with highly emetogenic risk antineoplastic agents: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023 from the Japan Society of Clinical Oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1632, doi. 10.1007/s10147-024-02624-x
    By:
    • Yokomizo, Ayako;
    • Nakashima, Kazuhisa;
    • Iba, Arisa;
    • Okita, Kenji;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi
    Publication type:
    Article
    48

    Defining the clinical benefits of adding a neurokinin-1 receptor antagonist to control chemotherapy-induced nausea and vomiting in moderately emetogenic chemotherapy: a systematic review and meta-analysis of the clinical practice guidelines for antiemesis 2023 from the Japan society of clinical oncology

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 11, p. 1616, doi. 10.1007/s10147-024-02623-y
    By:
    • Hayashi, Toshinobu;
    • Yamamoto, Shun;
    • Miyata, Yoshiharu;
    • Takeda, Masayuki;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    49

    Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
    By:
    • Kobayashi, Masamitsu;
    • Kako, Jun;
    • Iba, Arisa;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Akechi, Tatsuo;
    • Iihara, Hirotoshi;
    • Imamura, Chiyo K.;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi
    Publication type:
    Article
    50

    2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
    By:
    • Iihara, Hirotoshi;
    • Abe, Masakazu;
    • Wada, Makoto;
    • Iino, Keiko;
    • Akechi, Tatsuo;
    • Imamura, Chiyo K.;
    • Okuyama, Ayako;
    • Ozawa, Keiko;
    • Kim, Yong-Il;
    • Sasaki, Hidenori;
    • Satomi, Eriko;
    • Takeda, Masayuki;
    • Tanaka, Ryuhei;
    • Nakajima, Takako Eguchi;
    • Nakamura, Naoki;
    • Nishimura, Junichi;
    • Noda, Mayumi;
    • Hayashi, Kazumi;
    • Higashi, Takahiro;
    • Boku, Narikazu
    Publication type:
    Article